Publications by authors named "Daniel Janowitz"

Claim this Profile
P
Public Health.
Eva Glaeser, Ingo Kilimann, Moritz Platen, Wolfgang Hoffmann, Frederic Brosseron, Daniel Janowitz

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computational ontology framework for the synthesis of multi-level pathology reports from brain MRI scans.
Devesh Singh, Alice Grazia, Achim Reiz, Andreas Hermann, Slawek Altenstein, Daniel Janowitz

J Alzheimers Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unsupervised XAI framework for dementia detection with context enrichment.
Devesh Singh, Yusuf Brima, Fedor Levin, Martin Becker, Bjarne Hiller, Daniel Janowitz

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unsupervised XAI Framework for Dementia Detection with Context Enrichment.
Devesh Singh, Yusuf Brima, Fedor Levin, Martin Becker, Bjarne Hiller, Daniel Janowitz

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study.
Jule Filler, Marios K Georgakis, Daniel Janowitz, Marco Duering, Rong Fang

Lancet Reg Health Eur· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating cytokine levels and 5-year vascular recurrence after stroke: A multicenter prospective cohort study.
Lanyue Zhang, Mohamad Ali Antabi, Jana Mattar, Omar El Bounkari, Rong Fang, Daniel Janowitz

Eur Stroke J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer's disease.
Friederike Völter, Sebastian Eckenweber, Maximilian Scheifele, Florian Eckenweber, Fabian Hirsch, Daniel Janowitz

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease.
David Mengel, Ester Soter, Julia Maren Ott, Madeleine Wacker, Alejandra Leyva, Daniel Janowitz

Mol Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease stage-specific atrophy markers in Alzheimer's disease.
Hannah Baumeister, Helena M Gellersen, Sarah E Polk, René Lattmann, Anika Wuestefeld, Daniel Janowitz

Alzheimers Dement· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors.
Eva Gläser, Ingo Kilimann, Moritz Platen, Wolfgang Hoffmann, Frederic Brosseron, Daniel Janowitz

Alzheimers Res Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function.
Philine Marie Schirge, Robert Perneczky, Toshiaki Taoka, Adriana L Ruiz-Rizzo, Ersin Ersoezlue, Daniel Janowitz

Alzheimers Res Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease stage-specific atrophy markers in Alzheimer's disease.
Hannah Baumeister, Helena M Gellersen, Sarah E Polk, René Lattmann, Anika Wuestefeld, Daniel Janowitz

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk.
Luisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, Xiao Wang, Frederic Brosseron, Daniel Janowitz

Alzheimers Dement· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum.
Lena Haag, Elisa Lancini, Renat Yakupov, Gabriel Ziegler, Yeo-Jin Yi, Daniel Janowitz

Brain Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and clinical significance of post-stroke incident ischemic lesions.
Rong Fang, Marco Duering, Felix J Bode, Sebastian Stösser, Julius N Meißner, Daniel Janowitz

Alzheimers Dement· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects.
Lara Blömeke, Fabian Rehn, Marlene Pils, Victoria Kraemer-Schulien, Anneliese Cousin, Daniel Janowitz

Commun Med (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locus coeruleus signal intensity and emotion regulation in agitation in Alzheimer's disease.
Kathy Y Liu, Matthew J Betts, Dorothea Hämmerer, Emrah Düzel, Mara Mather, Daniel Janowitz

Brain Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease.
Filippo Martinelli, Almut Heinken, Ann-Kristin Henning, Maria A Ulmer, Tim Hensen, Daniel Janowitz

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics.
Matthias Brendel, Tandis Parvizi, Johannes Gnörich, Christof Elias Topfstedt, Katharina Buerger, Daniel Janowitz

Alzheimers Dement (Amst)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies.
Roxane Dilcher, Stephan Wall, Mattes Groß, Sabrina Katzdobler, Olivia Wagemann, Daniel Janowitz

Alzheimers Dement· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline.
Xiao Wang, Silka D Freiesleben, Luisa-Sophie Schneider, Lukas Preis, Josef Priller, Daniel Janowitz

Neurology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal evidence for a mutually reinforcing relationship between white matter hyperintensities and cortical thickness in cognitively unimpaired older adults.
Jose Bernal, Inga Menze, Renat Yakupov, Oliver Peters, Julian Hellmann-Regen, Daniel Janowitz

Alzheimers Res Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perivascular space enlargement accelerates in ageing and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study.
Inga Menze, Jose Bernal, Pinar Kaya, Çağla Aki, Malte Pfister, Daniel Janowitz

Alzheimers Res Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts.
Kai Shao, Xiaochen Hu, Luca Kleineidam, Melina Stark, Slawek Altenstein, Daniel Janowitz

Alzheimers Dement· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.
Jonathan Vogelgsang, Niels Hansen, Melina Stark, Michael Wagner, Hans Klafki, Daniel Janowitz

Alzheimers Dement· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis